E-cigarettes: regulations for consumer products

AI Summary

The Medicines and Healthcare products Regulatory Agency (MHRA) serves as the competent authority for the United Kingdom’s vaping product notification scheme, operating under the Tobacco and Related Products Regulations 2016 (TRPR). This regulatory framework, updated by the 2020 EU Exit Regulations, mandates strict safety and quality standards for nicotine-containing e-cigarettes and refill containers across Great Britain and Northern Ireland. Key requirements include limiting tank capacity to 2ml, refill volumes to 10ml, and nicotine concentration to 20mg/ml. Products must also feature child-resistant packaging, exclude banned ingredients such as caffeine or taurine, and adhere to specific labeling and warning standards. Required actions apply to all producers—including manufacturers, importers, and re-branders—who must formally notify the MHRA before any product can be legally sold. Following the policy implementation on January 1, 2021, producers must utilize the EU Common Entry Gate (EU-CEG) for Northern Ireland markets and a domestic UK system for Great Britain. A single notification fee applies regardless of whether a product is registered for one or both territories. These regulations are designed to ensure product safety, facilitate informed consumer choices, and prevent nicotine use among children. Retailers are generally exempt from notification unless they also function as producers, while medicinal nicotine products are handled under separate licensing systems.